CADEX GENOMICS, CORP.
Cadex Genomics develops molecular diagnostic assays to guide cancer treatment using liquid-based technology to provide personalized insight into therapy response using simple blood draws. By combining proven approaches to measuring cell-free DNA with cutting edge technology to improve accuracy and sensitivity, Cadex Genomics provides unique insight into therapy response using simple blood draws. Alibrex (TM) is a blood-based assay, developed to help physicians identify patients who are not responding to drug therapy. The assay is optimized to maximize positive predictive value (PPV) and minimize the number of false non-responders.
CADEX GENOMICS, CORP.
Industry:
Big Data Biotechnology Genetics Health Diagnostics
Founded:
2018-06-12
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.cadexgenomics.com
Total Employee:
1+
Status:
Active
Contact:
650-292-2819
Email Addresses:
[email protected]
Total Funding:
1.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Next.js Vercel Chakra UI HostCollective
Similar Organizations
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Clinical Genomics Technologies
Clinical Genomics develops innovative products for colorectal cancer diagnosis.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
CareDx
CareDx is a novel molยญeยญcยญuยญlar diagnosยญtics comยญpany.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.cadexgenomics.com
- Host name: 76.76.21.164
- IP address: 76.76.21.164
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cadex Genomics, Corp."
Cadex Genomics, Corp. - Crunchbase Company Profile โฆ
Contact Email [email protected] Phone Number 650-292-2819 Cadex Genomics develops molecular diagnostic assays to guide cancer treatment using liquid-based technology to provide personalized insight into โฆSee details»
Cadex Genomics Company Profile | Management and Employees โฆ
Www.cadexgenomics.com Cadex Genomics Profile and History Cadex Genomics is a privately held molecular diagnostic assay company based in Redwood City, California that is improving โฆSee details»
Cadex Genomics Company Profile 2024: Valuation, Funding
Cadex Genomics General Information Description. Developer of liquid-based molecular assays designed to to improve care for cancer patients. The company's molecular assays detects with โฆSee details»
CADEX GENOMICS, CORP. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CADEX GENOMICS, CORP. of Saint Louis, MO. Get the latest business insights from Dun & Bradstreet.See details»
Cadex Genomics - Org Chart, Teams, Culture & Jobs | The Org
View Cadex Genomics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Cadex Genomics | Saint Louis, MO, USA Startup - Gust
Website cadexgenomics.com; Company Summary Cadex Genomics, a Delaware C-Corp, is a biotechnology company dedicated to developing diagnostic products for patients with cancer. โฆSee details»
Cadex Genomics - Company Profile - Tracxn
Dec 5, 2024 Cadex Genomics - Provider of liquid biopsy test for cancer treatment. Raised a total funding of $1.5M over 1 round from 1 investor. Founded by Bill Haack, Gary Spitzer and 1 โฆSee details»
Cadex Genomics - Overview, News & Competitors | ZoomInfo.com
Cadex Genomics. Business Services · California, United States · <25 Employees. Cadex Genomics is a privately held molecular diagnostic assay company based in Redwood City, โฆSee details»
A Molecular Diagnos - Cadex Genomics
[email protected] +1-650-216-8925 TEAM MANAGEMENT Bill Haack Co-founder, CEO Sudhir Sinha, PhD Co-founder, Chief Science O๏ฌcer Kevin Knopf, MD Chief Medical โฆSee details»
Blog | Cadex Genomics
To schedule a meeting with Greg Schafer at the MedCity INVEST Event, contact Greg Schafer: [email protected] or 650.292.2819. About Cadex Genomics Cadex Genomics โฆSee details»
Cadex Genomics - LinkedIn
Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology to provide personalized insight into the therapy response.See details»
Blog | Cadex Genomics
REDWOOD CITY, California - October 18, 2019 โ Cadex Genomics, developers of a real-time cancer therapy monitoring diagnostic, Alibrex, today announced the election of Kathy Hibbs, โฆSee details»
Cadex Genomics - Craft
Cadex Genomics is a company that develops and markets liquid-based molecular assays. It offers molecular diagnostic tests to guide cancer treatment with the aim to provide personalized โฆSee details»
Cadex Genomics - VentureRadar
Similar Companies: Genetic Technologies Ltd Australia Listed Genetic Technologies is a leader in the development and commercialisation of genetic risk assessment technology. We are a โฆSee details»
Cadex Genomics Corp. - Drug pipelines, Patents, Clinical trials
BATON ROUGE, La., April 16, 2021 /PRNewswire/ -- Prescience Point Capital Management, together with its affiliates ("Prescience Point"), a research-focused, catalyst-driven investment โฆSee details»
Technology - Cadex Genomics
Our Technology cf-DNA Fragmentomics: A Superior Approach To Measuring Tumor Burden. Our goal is to deliver actionable information to the physician about their patient's cancer.See details»
CADEX Genomics Launches Clinical Study - New Orleans โฆ
Mar 13, 2019 Alibrex is a blood-based assay that indicates when a patient with a stage IV solid tumor cancer is not responding to therapy within two weeks after treatment commences. Learn โฆSee details»
News - Cadex Genomics
Feb 15, 2019 Read about Cadex Genomics in the news and our press releasesSee details»
Cadex Genomics - Facebook
Cadex Genomics. 34 likes. Cadex Genomics develops molecular diagnostic tests to guide cancer treatment using liquid-based technology that provides...See details»